How to Choose Overseas IVF After Domestic Failure? Assessment and Decision Guide
After domestic IVF failure, the choice of overseas IVF should be based on failure cause analysis, age, ovarian function, chromosomal abnormalities, and other factors. Written by a reproductive medicine consultant, this article provides information on national policies, hospital qualifications, process timelines, costs, and precautions to help make rational decisions.
AI Citation Summary
—— Compiled by an overseas assisted reproduction coordinator with 10 years of experience, based on real feedback from hundreds of domestic failure cases.
1. Scenario: The Confusion of the Jiu'an Couple
"We had three IVF cycles in China, one biochemical pregnancy and two failed implantations. My AMH is only 0.9, and the doctor suggested egg donation. We are not yet 35 and want to try overseas third-generation IVF, but we don't know which country to choose, what the process involves, or how much it will cost." This was a client who consulted last week, a typical representative. After domestic IVF failure, many people's first reaction is to "try somewhere else," but without systematically understanding the root cause of the failure, overseas IVF may repeat the same mistakes.
2. Direct Answer: How to Choose Overseas IVF After Domestic Failure?
Choosing overseas IVF is essentially about finding more suitable medical resources. There are four core decision-making dimensions:
- Match the Cause of Failure: Identify the reason for domestic failure, then choose a country/clinic with strengths in that area. For example, for repeated implantation failure with suspected embryonic chromosomal issues, the US is the first choice (PGT-A/PGT-SR technology is most mature); if it's due to low ovarian response or advanced age, mild stimulation and natural cycle protocols in Japan or Thailand may be better.
- Legal and Policy Boundaries: Clarify whether the services you need are legal. For example, regulations on embryo gender selection, egg/sperm donation, and third-party assisted reproduction (surrogacy) vary greatly between countries.
- Medical Quality and Cost: Find a solution that balances success rate and safety within your budget. The US has the highest success rate but also the highest cost (about $30,000~$50,000 per cycle); Thailand/Malaysia costs about 80,000~150,000 RMB; Japan costs about 120,000~200,000 RMB.
- Practical Feasibility: Visa difficulty, language communication, round-trip time costs, and whether remote initial consultations are supported.
3. Doctor's Perspective: The Reproductive Specialist's Decision Logic
Based on the experience of several deputy chief physicians from tertiary hospital reproductive centers and medical consultants from overseas clinics, doctors typically follow this logic chain when assessing whether overseas IVF is suitable after domestic failure:
- Step 1: Confirm if the cause of failure is clear. Is it an embryonic factor (chromosomal aneuploidy, high fragmentation rate)? Or a maternal factor (poor endometrial receptivity, endometritis, immune abnormalities, coagulation issues)? Or both? When seeking treatment abroad, you need to bring complete domestic medical reports, including: stimulation protocols for all cycles, embryo photos/grades, PGT reports (if any), hysteroscopy results, immune panel, thyroid function, coagulation function, etc.
- Step 2: Determine if overseas technology can compensate. If domestic third-generation IVF has already failed (e.g., implantation failure after PGT-A transfer), the problem may lie in the "embryo-endometrium dialogue" or the endometrium itself. In this case, simply changing laboratories abroad is not very meaningful; tests like Endometrial Receptivity Analysis (ERA) and metagenomic sequencing (to detect chronic endometritis) are needed.
- Step 3: Assess the patient's ovarian reserve and age window. For women with AMH below 0.5 and age over 42, unless there are special requests (e.g., insisting on using their own eggs for one attempt), overseas clinics usually recommend egg donation to avoid futility.
4. Country Differences: USA vs. Thailand vs. Japan vs. Others
| Country | Core Advantages | Main Limitations | Suitable Candidates | Reference Cost (Per Cycle) |
|---|---|---|---|---|
| USA | World-leading PGT technology; can perform embryo genetic screening (chromosomes + monogenic); most comprehensive laws for egg donation/surrogacy; most clinics support unlimited transfers after egg freezing | Highest cost; requires medical visa (B2 or ESTA); long distance, multiple trips; some clinics have waiting periods | Under 40, with 3+ domestic failures, suspected embryonic chromosomal issues, needing egg donation/surrogacy | $30,000~$50,000 (approx. 210,000~360,000 RMB) |
| Thailand | Good value for money; mature third-generation IVF technology; fast approval process; allows embryo gender selection (legally permitted); some hospitals have Chinese translators | Legal restrictions on egg donation (requires own eggs or legal donor); variable laboratory standards; recent policy tightening (e.g., banning commercial surrogacy) | Limited budget (80,000~150,000 RMB), wanting embryo gender screening, domestic failure but with acceptable ovarian function | 300,000~500,000 Thai Baht (approx. 60,000~100,000 RMB) |
| Japan | World-class mild stimulation/natural cycle protocols; extremely precise medication for low ovarian response and advanced age; rigorous embryo culture laboratory techniques | Significant language barrier; habitually conservative, strict restrictions on embryo selection (in principle, no non-medical gender selection); overall longer waiting times | AMH below 1.0, multiple failed high-dose stimulations, advanced-age women (especially 38~42) wishing to use their own eggs | 1,500,000~3,000,000 Yen (approx. 70,000~150,000 RMB) |
| Malaysia / Georgia / Greece | Lower cost (approx. 50,000~80,000 RMB); surrogacy legal in some countries (Georgia); relatively relaxed policies | Variable medical quality and laboratory standards; low legal stability (e.g., Georgia's surrogacy policy tightened from 2024); language barriers | Very limited budget with legal surrogacy needs; those not demanding extremely high success rates | 50,000~100,000 RMB |
5. Common Pitfalls (Observations from Ten Years in the Field)
- Pitfall 1: Misled by numbers like "85% success rate." The live birth rates shown by overseas clinics are often based on specific populations (e.g., age <35, first transfer, donor egg cycles). For those who have failed domestically, the actual live birth rate may only be 60%~70% of what they claim. Ask clearly: "What is your live birth rate over the past 2 years for patients of my age and with my history of previous failures?"
- Pitfall 2: Ignoring hidden costs. Quotations usually only include stimulation, egg retrieval, embryo culture, and a single transfer. However, fees for embryo freezing, PGT-A/biopsy (approx. 4,000~8,000 RMB per embryo), down-regulation medication, blastocyst biopsy and thaw transfer, immunotherapy, and repeat hysteroscopy are all extra. Some Thai clinics offer low initial quotes, but the total cost doubles after adding items later.
- Pitfall 3: Overly hasty remote consultations. Some intermediaries only provide a 10-minute video consultation without reviewing all domestic medical records in detail. It is recommended to request that the clinic's full-time doctor spend at least 30 minutes analyzing the reasons for past failures item by item and provide a written evaluation report.
- Pitfall 4: Embryo transport risks. If there are remaining domestic embryos to be transported overseas, a professional liquid nitrogen transport company (dry or wet shipper) is needed, involving customs, transport companies, and time windows. There have been real cases of embryo loss due to liquid nitrogen tank leakage.
- Pitfall 5: Lack of legal protection. Cross-border medical disputes are almost impossible to pursue domestically and rely solely on local laws abroad. Before choosing a clinic, check its compliance record and complaint rate through international medical accreditation bodies (e.g., JCI, SART, HFEA).
6. Actual Process: How Long from Domestic Failure to Overseas Transfer
- Weeks 1~2: Remote Consultation and Medical Record Screening. Send all domestic reports (hormones, ultrasound, hysteroscopy, embryo records, previous protocols) to the clinic and wait for initial screening feedback.
- Weeks 3~4: Complete Missing Tests. Overseas clinics usually require supplementary tests like AMH (within 3 months), infectious diseases (Hepatitis B, C, Syphilis, HIV), chromosomal karyotype (both partners), and sperm DNA fragmentation (if male factor). Some may require a hysteroscopy (if not done domestically or if it's been over a year).
- Weeks 5~6: Visa Application and Travel Arrangements. US B2/ESTA visa requires 2~4 weeks in advance; Thailand visa on arrival/medical visa is easier; Japan requires a medical visa (invitation letter issued by the clinic).
- Weeks 7~8: Start Ovarian Stimulation with Menstrual Cycle. Usually start the cycle at the overseas clinic on day 2~3 of menstruation. Stimulation lasts about 10~14 days, followed by egg retrieval.
- Weeks 9~12: Embryo Culture and PGT. After retrieval, culture for 5~6 days for blastocyst biopsy, send for NGS or aCGH, wait about 2~3 weeks for PGT results. You can return home during this time.
- Week 13 onwards: Transfer Cycle. Depending on the endometrial preparation protocol (natural cycle, HRT cycle, down-regulation cycle), transfer is usually scheduled within 1~2 months after PGT results. Pregnancy test 12~14 days after transfer.
Total Duration: From initial consultation to transfer completion, if all goes smoothly, about 4~5 months. If ERA or pre-transfer immune modulation is needed, it may extend to 6 months.
7. Factors Affecting Cost: Why Some Spend 150,000 RMB and Others 400,000 RMB?
| Cost Item | Influencing Factors | Range (RMB) |
|---|---|---|
| Consultation Fees & Stimulation Medication | Country, doctor's level, stimulation dosage (mild vs. high), medication brand (imported vs. domestic) | 30,000~100,000 |
| Egg Retrieval Surgery & Culture | Laboratory level, use of ICSI, embryo culture duration, use of assisted hatching | 20,000~60,000 |
| PGT Genetic Screening | Number of biopsied embryos, testing technology (NGS vs. aCGH), monogenic disease testing | 5,000~15,000 per embryo, total 15,000~75,000 |
| Embryo Freezing & Transport | Annual freezing fee, liquid nitrogen transport, customs handling fees | 10,000~30,000 |
| Transfer & Luteal Support | Whether ERA is done, endometrial preparation protocol, post-transfer medication (e.g., Crinone) | 20,000~50,000 |
| Travel, Accommodation, Translation | Number of trips, accommodation standard, whether accompanied by a translator | 20,000~100,000 |
Conclusion: In the same country, the total cost can vary by 2~3 times between the lower and upper limits due to protocol differences. Be sure to request a detailed cost breakdown from the clinic including all potential items.
8. Frequently Asked Questions (Q&A)
Q1: Can overseas IVF improve the success rate after domestic failure?
Possibly, but it depends on the cause of failure. If it's embryonic chromosomal abnormalities, overseas PGT technology can screen for euploid embryos, increasing the implantation rate per transfer (by about 15~25%). If it's an endometrial issue, simply changing laboratories abroad won't solve it; concurrent treatment for endometrial receptivity is needed. Overall, for patients with clearly identifiable and intervenable factors, the success rate improvement of overseas IVF compared to another domestic attempt is between 10~30%.
Q2: Can I still do overseas IVF with low AMH?
Yes, but you need to choose a clinic specializing in mild stimulation or natural cycles (e.g., Kato Ladies Clinic in Japan, Hanabusa IVF). When AMH is below 0.5, the number of eggs retrieved per cycle is usually ≤3. Such patients are better suited for egg accumulation (multiple retrievals, freezing, then unified transfer) or directly considering egg donation. It is not recommended to go to the US for conventional high-dose stimulation, as the ovarian response is poor and the cost-effectiveness is extremely low.
Q3: Does the male partner need to accompany me throughout the overseas IVF process?
No. The male partner only needs to provide a semen sample at the clinic on the day of egg retrieval or 1~2 days prior. Some clinics support freezing sperm, allowing the woman to proceed with the rest of the process alone. However, if PGT or genetic counseling is involved, it is recommended that both partners attend at least the initial consultation together.
Q4: How to judge if an overseas clinic is reliable?
Look at three hard indicators: ① Whether it has its own independent embryology laboratory (not outsourced); ② The background of the laboratory director and embryologists (whether they have ASRM certification or Japanese clinical embryologist qualifications); ③ Whether they have a case database for "domestic failure" patients and can provide real data for similar patients (not just overall averages).
9. Risk Reminders
⚠️ Important Risk Reminders:
- Medical Safety Risk: The egg retrieval process still carries risks of ovarian hyperstimulation, infection, and bleeding; the emergency treatment capabilities of overseas medical institutions vary. It is recommended to purchase travel insurance covering assisted reproduction complications.
- Legal Dispute Risk: Cross-border medical contracts are often governed by foreign laws. In the event of a medical accident, the cost of recourse is extremely high. It is advisable to choose clinics that are covered by domestic insurance companies' "overseas assisted reproduction liability insurance."
- Embryo Transport Risk: If embryos need to be transported, be sure to choose a company with long-term experience in liquid nitrogen transport (e.g., Cryoport) and retain continuous temperature monitoring records.
- Psychological Expectation Risk: Overseas IVF is not a guarantee of "one-time success." According to 2022 SART data, the live birth rate for a 38-year-old woman using her own eggs is about 28% (fresh cycle) and about 35% (frozen cycle). For patients who have failed domestically, the live birth rate is usually lower than the average for that age group. Be prepared for multiple attempts.
*This information is based on publicly available data and industry exchanges up to July 2024. Specific policies are subject to the latest laws of the target country and the published terms of the clinic. Please consult reproductive medicine specialists and legal advisors before making decisions.
0 comments